Unicycive Therapeutics (UNCY) announced a change in the time of the 2025 Annual Meeting of Stockholders. The previously announced date of the meeting and location of the meeting will not change, but the meeting will be held at 7:00 a.m., Pacific Daylight Time, on that date.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on UNCY:
- Buy Rating for Unicycive Therapeutics Driven by Strategic Positioning and Upcoming Regulatory Milestones
- Unicycive Therapeutics reports Q1 EPS (5c), consensus (6c)
- Unicycive Therapeutics initiated with a Buy at Guggenheim
- Buy Rating for Unicycive Therapeutics: Competitive Advantages of Oxylanthanum Carbonate in Hyperphosphatemia Treatment
- Unicycive Therapeutics: Buy Rating on Imminent FDA Approval and Market Potential of Oxylanthanum Carbonate